1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
60CDE591E359C8B2585257BFF006F7599
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/biopharmaco-1000-busines-models-to-ensure-long-term-health-and-prosperity
18
19
203.90.12.112
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Business Operations » Organizational Strategy and Structure

BioPharmaCo at 1000: New Business Models to Ensure Long-term Health, Prosperity & Survival

DB Image

ID: 5273


Features:


Pages/Slides: 7


Published: 2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Please click on "Add to Cart" to obtain the article on "BioPharmaCo at 1000: New Business Models to Ensure Long-term Health, Prosperity & Survival."


Document Overview

"PharmaCo at 1000: New Business Models to Ensure our Long-term Health, Prosperity & Survival" is a 7-page paper that uses examples in nature and in the corporate world to illustrate how a company - a biopharmaceutical company in particular - can ensure its long-term survival.

The article, which was jointly written by Daniel Pascheles, vice president at Merck & Co., and Christopher Bogan, chief executive officer at Best Practices®, LLC., addresses which survival traits characterize health, resilience and longevity in a modern corporation and which business models enhance the likelihood of long-term survival in the current turbulent environment.

The paper uses IBM and General Electric as corporate case studies in successfully adapting to changes in the business world.


Industries Profiled:
Market Research; Manufacturing; Medical Device; Pharmaceutical; Financial Services; Service; Retail; Research; Computer Software; Diagnostic; Health Care; Transportation; Biotech; Clinical Research; Consulting; Distribution; Insurance; Hospitality; Telecommunications; Technology; Professional Services; High Tech; Automobile; Utilities; Energy; Consumer Products; Chemical; Medical; Electronics; Laboratories; Biopharmaceutical; Banking; Computers; Entertainment; Internet; Computer Hardware; Aerospace; Academic; Media; Education; Newspapers; Government; Shipping; Science; Office Supplies; Marketing; Office Equipment; Cable; Advertising; Defense; Military; Diversified; Sports; Technology; Public Relations; Multiple; Communications; Logistics; Publishing; Real Estate; Construction; Architecture; Engineering; Aviation; Legal; Test Industry; Non-Profit; Business; Orthopaedics


Companies Profiled:

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.